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Abstract: Loneliness has been associated with poor mental health and wellbeing. In England, a 2018
national strategy on loneliness was published, and public health guidelines recommend participation
in social activities. In the absence of existing economic evidence, we modelled the potential cost
effectiveness of a service that connects lonely older people to social activities against no-intervention.
A 5-year Markov model was constructed from a health and social care perspective. Parameters were
drawn from the literature, with the intervention structure based on an existing loneliness alleviation
programme implemented in several settings across England. Univariate and probabilistic sensitivity
analyses were undertaken. The total expected cost per participant in the intervention group is
£7131 compared to £6783 in the usual care group with 0.45 loneliness free years (LFY) gained. The
incremental cost per LFY gained is £768; in the probabilistic sensitivity analysis the intervention
is cost saving in 3.5% of iterations. Potentially such interventions may be cost-effective but are
unlikely to be cost-saving even allowing for sustained effects and cumulative adverse health and
social care events averted. Empirical studies are needed to determine the cost-effectiveness of these
interventions, ideally mapping changes in loneliness to the quality of life, in order to allow the key
metric in health economic studies, cost per quality adjusted life year to be estimated.
Keywords: cost-effectiveness analysis; social activities; loneliness; older people
1. Introduction
Loneliness can be thought of as a subjective, unpleasant, and distressing phenomenon
resulting from a discrepancy between an individual’s desired and achieved levels of social
relations [1]. Even though periods of loneliness for all of us are an inevitable part of life,
there is increasing evidence suggesting that enduring loneliness potentially can have an
adverse impact on mental and physical health across different age groups [2–5]. The risk
of premature death may also be associated with more severe levels of loneliness in older
people [6–8].
The policy interest in measures to reduce loneliness in England is high, with the
creation of a ministerial post with a specific responsibility for loneliness, and publication of
a national strategy to address the issue in 2018 [9]. The issue of loneliness, and potential
impacts on mental health in particular, has also been highlighted by England’s Chief
Medical Officer as one key adverse consequence of ongoing measures to enforce social
distancing and minimise physical contacts during the current COVID-19 pandemic [10].
Loneliness has also been recognised as a risk factor for poor mental health and well-
being by the National Institute for Health and Care Excellence (NICE), an independent
authority that makes recommendations on appropriate public health interventions in Eng-
land. Evidence on the effectiveness of approaches to tackle loneliness that include a strong
element of socialisation and group activities is growing [11]. Current NICE guidelines to
promote the mental health and wellbeing of older people include support for actions to
both publicise, and if there is not enough existing provision, consider providing a range of
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group-based social activities that meet the needs and interests of people who have retired
from work [12].
Potentially investment in programmes to address loneliness in older people through
socialisation and group activities, if effective, may also be cost-effective from a public
health perspective, promoting better physical and mental health and wellbeing across the
population. However, there remains relatively little evidence on the cost-effectiveness and
resource implications of interventions whose primary goal is to reduce loneliness [13].
In the absence of such empirical data from trials, health economic modelling studies
are widely used to help determine the potential strength of the economic case for action [14].
Models essentially are mathematical frameworks that estimate the consequences of dif-
ferent policy and practice decisions. They can be used to bring together evidence on the
effectiveness, resource use, and costs from multiple sources to help reduce the level of
uncertainty for decision makers associated with an investment in any intervention. They
can look at the likelihood of cost-effectiveness, that is whether the additional benefits of
any action are worth the additional costs required to achieve them, under a wide range of
conditions, varying many different assumptions on costs, uptake, effects, and outcomes.
One of the principal approaches is Markov modelling. It has the advantage of being
able to model uncertain processes over multiple time periods known as cycles and reflect
circumstances where individual health and outcomes can fluctuate. This means that
Markov models can also be used for projecting longer-term costs and outcomes than
may be practical in empirical studies, such as a very long-term follow up on the costs and
benefits of a mental health treatment in older adults [15]. There are many other applications
of these models in health economics. For instance, they have been used to look at the
cost-effectiveness of different cancer treatments [16], where at different points in time
individuals may be in different disease states, including remission, recurrence or death, as
well as the economic case for preventive interventions such as screening programmes [17].
Markov modelling has also been used by public health agencies in England to help support
local decision makers, for instance, to develop their mental health promotion and disorder
prevention strategies, including work to prevent bullying in schools, suicide in adults, and
poor mental health in older people [18].
Given the lack of information on the cost-effectiveness of loneliness alleviation pro-
grammes, this paper describes a decision-analytical Markov model that provides illustrative
information on a service intended to alleviate loneliness in people aged 65 and older. The
model synthesises short term costs and experience in tackling loneliness in England with
information on the potential health and social care benefits that may be gained through a
reduction in loneliness over a 5-year time period. The comparator in the model is assumed
to be no intervention.
The service modelled is assumed to be similar to many local signposting services of-
fered in a number of locations in England to help older people make new social connections
in their community. As an illustrative example, we assume that our model intervention is
similar to that offered by Reconnections, a personalised support and community response
service to loneliness initially operated in Worcestershire in southern England since 2015 [19]
and now also replicated in Surrey and London.
This service was created in 2015 by Social Finance, a not for profit organisation that
strives to find better ways of tackling social problems in the UK. It is also the first service in
the UK to be funded through a social impact bond to tackle loneliness. These bonds provide
an investment to address social problems and look to fund preventative interventions.
They link financial success to the delivery of measured social outcomes. If, and only if, the
social outcome improves (in this case loneliness), the outcome payor repays the investors
for their initial investment plus a return for the financial risks they took.
The service works with older people to understand their individual strengths and
needs; rebuilding confidence and supporting them to connect with people, places, or
activities in their community. For example, individuals may benefit from a focus on arts-
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related activity, sport and exercise, spirituality, connections with local communities or those
with whom they share an identity, and/or on enhancing their online lives.
2. Materials and Methods
2.1. Model Structure
A four-state Markov model has been constructed. Figure 1 illustrates the principal
model pathways. The model runs over five cycles with each cycle lasting one year, com-
paring participation in the service against no intervention All individuals in the model
initially are assumed to have moderate or severe levels of loneliness, reflecting the eligi-
bility criteria in Reconnections, where only older people with initial scores between 7 to 9
(moderate loneliness) and 10 to 12 (severe loneliness) using the four-item version of the
UCLA-Loneliness scale [20] were eligible for participation.
The model assumes, that in the first year of the model, the intervention group receives
support for a period of between 6 and 9 months from a trained volunteer who helps
identify opportunities to participate in a wide range of local community activities with
the objective of reducing loneliness, as well as improving health and wellbeing. Beyond
this time period, the aim is for service users to continue with the new social activities that
they have been pursuing. After the first year, participants either continue to participate
in their chosen activities (at their own cost) or may disengage from these activities. The
model assumes that changes in loneliness achieved during the first year of support from
Reconnections potentially can be sustained (to different extents) over a further 4 years if
individuals continue to participate in community activities. To be conservative no further
benefits are assumed to accrue to individuals who drop out of the programme.
The model then considers the potential impacts of participation in the service on time
spent in one of four mutually exclusive different states: Not lonely, moderate lonely (lonely
some of the time), severely lonely (lonely most of the time), and death for the intervention
and no intervention groups. In each cycle, individuals can transition between each of these
states, as well as into the finite death state.
Due to their social impact bond contractual obligations, Reconnections routinely
assessed the loneliness scores of all their clients at a 1-year follow up. This meant that
aggregate information on changes in loneliness outcomes for more than 1200 participants
from this non-randomised case study were available to estimate transition probabilities,
allowing us to make a preliminary estimate of the potential effectiveness of these pro-
grammes.
Looking at the outcomes, utility values used for the quality of life cannot currently be
mapped to states of loneliness. Therefore, in this model, we simply assume that each cycle
(year) spent in the state of not being lonely has a value of 1, while each cycle spent severely
lonely has a value of 0. We assume that each cycle spent moderately lonely has a value of
0.5. The model then looks at the potential increased risks associated with different levels
of loneliness in the intervention and no intervention groups for poor health and related
need for additional health and social care service utilisation, compared with individuals
who are not lonely in each cycle. Resource use and costs associated with differing risks
of poor physical and mental health for different states of loneliness are also computed for
each model cycle. We do not include additional costs related to death, assuming these to
be the same for both intervention and non-intervention groups. Cumulative loneliness free
time and total costs over the 5-year period are calculated for both groups. The incremental
cost per additional hypothetical loneliness free year gained is then estimated.
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Table 1 summarises parameters used in the model, assumptions on distributions used
in the probabilistic sensitivity analysis (PSA), sources for data and transition probabilities.
We have modelled potential additional health and social care costs for several conditions
where a significant association between loneliness and a greater 1-year incidence of chronic
illness has been reported. These include systematic reviews and meta-analyses that have
reported an association between loneliness and major chronic health conditions, including
stroke and coronary heart disease [5] and dementia [21]. A recent analysis of multiple
waves of the English Longitudinal Survey on Ageing (ELSA) reports an association between
loneliness at baseline and long-term higher levels of depression [4], while an analysis
of the cross-sectional Adult Psychiatric Morbidity survey in England also suggests an
association between both severe and moderate levels of loneliness and rates of intentional
self-harm [22]. Loneliness has also been shown to be a risk factor for nursing home
admission in logistic regression models making use of ELSA data [23]. In England, severe
loneliness has been associated with a higher utilisation of primary care general practitioner
(GP) services [24,25], as well as hospital accident and emergency services compared to
the non-lonely [25]. A recent analysis of data from the Survey of Health, Ageing and
Retirement in Europe (SHARE) also suggests a significant association between the greater
use of GP services and being socially isolated [26].
Table 1. Model parameters.
Input Parameter Deterministic Value Distribution in PSA Source
Costs
Accident and emergency department attendance (per visit).
Assumed as the National Tariff Emergency Medicine 2019/20 VA
Category 2 investigation with Category 2 treatment VB07Z
£ 163 Gamma [27]
Ambulance (per emergency) using National Tariff 2018/19
ASSO2 See, Treat and Convey Tariff £ 257 Gamma [28]
Coronary Heart Disease (Annual) £ 1637 Gamma [29]
Dementia: Health and social care (Annual) £ 19,383 Gamma [30]
Dementia: Informal care (Annual) £ 15,858 Gamma [30]
Depression (Annual) £ 961 Gamma [31]
GP (per contact) £ 39.23 Gamma [32]
Hospital admission (per admission) £ 631 Gamma [32]
Intervention Cost (per client) £ 752 Gamma [33]
Residential care (private residential care home) (per week) £ 691 Gamma [32]
Self-harm treatment (per hospital presentation) £ 895 Gamma [34]
Stroke: Health and social care (annual) £ 8833 Gamma [35]
Stroke: Informal care (annual) £ 22,589 Gamma [35]
Incidence among over 65s
Coronary heart disease 0.011 Beta [36]
Dementia 0.008 Beta [36]
NHS presenting depression 0.017 Beta [37]
Stroke 0.003 Beta [36]
Hospital presenting self-harm 0.001 Beta [38]
Residential care admission 0.019 Beta [39]
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Table 1. Cont.
Input Parameter Deterministic Value Distribution in PSA Source
Increased relative risk of event if severely lonely
Coronary heart disease 1.29 Log Normal [5]
Dementia 1.58 Log Normal [21]
Depression 1.23 Log Normal [4]
GP Contact 1.86 Log Normal [24]
Residential care admission 2.13 Log Normal [23]
Stroke 1.32 Log Normal [5]
Self-harm 17.37 Log Normal [22]
Death 1.30 Log Normal [6]
Other
Percent of participants initially severely lonely at baseline with
UCLA-4 scores >9 0.44 Beta [33]
Percent of participants initially moderately lonely at baseline with
UCLA-4 scores <9 and >6 0.56 Beta [33]
Probability of becoming not lonely after an intervention 0.191 Beta [33]
Annual probability of death in the over 65 population (assumed
to be the rate for both genders aged 70) 0.015 Beta [40]
Expected number of GP contacts per annum in over 65s 7.70 Gamma [41]
Probability of dropout 0.89 Beta [33]
Volunteering value (per hour)
(Assumed equivalent to the national minimum wage for over 21s) £ 0.21 Fixed [42]
Probability of the participant becoming a permanent volunteer 0.003 Fixed [43]
Annual Transition probabilities
With Intervention
Severely lonely to moderately lonely 0.444 Beta [33]
Severely lonely to not lonely 0.187 Beta [33]
Moderately lonely to severely lonely 0.351 Beta [33]
Moderately lonely to not lonely 0.188 Beta [33]
Not lonely to severely lonely 0.351 Beta [33]
Not lonely to moderately lonely 0.446 Beta [33]
Without intervention
Severely lonely to moderately lonely 0.549 Beta [33]
Severely lonely to not lonely 0 Beta [33]
Moderately lonely to severely lonely 0.433 Beta [33]
Moderately lonely to not lonely 0 Beta [33]
Not lonely to severely lonely 0.433 Beta [33]
Not lonely to moderately lonely 0.552 Beta [33]
In the model, with the exception of self-harm, we assume conservatively that any
increased incidence in poor physical and mental health only applies to individuals who
experience severe levels of loneliness. This may underestimate the benefits to the health
and social care sectors of reducing moderate levels of loneliness, but insufficient data are
available in the literature. We also assume that 44% of model participants initially meet the
criteria for severe levels of loneliness based on the experience reported by Reconnections
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with their programme. For illustrative purposes in our baseline analysis, we assume that
there would be a 19.5% reduction in individuals who received the intervention being either
severely lonely or moderately lonely at a 1-year follow up based on the experience in
Reconnections for individuals who had the most severe levels of loneliness at baseline.
These figures must be treated cautiously given there is no counterfactual comparison data
on individuals who declined to participate in Reconnections. Nonetheless, our model
assumption may be conservative as almost 40% of individuals with moderate levels of
loneliness at baseline in Reconnections had UCLA4 scores of 6 or less at a 1-year follow
up and were no longer deemed lonely. Without intervention, we assume no change in the
loneliness state. The annual sustained participation rate is assumed to be 89%, as seen with
Reconnections over a 2-year period.
2.2. Analysis Perspective
Our primary analysis is conducted from a health and social care perspective. Health
and social care service costs in England for physical and mental health conditions that
may be associated with loneliness, including the greater use of primary and long-term
residential care services, are shown in Table 1. The total budget for the service was divided
by the number of participants that served to estimate the mean intervention cost per
client [33]. Table 1 also includes the costs of additional informal care related to dementia
and strokes. These impacts on informal care are included in our secondary analysis, along
with the benefits from programme participants themselves becoming volunteers. We use a
very conservative likelihood of participants becoming volunteers for 3 h per week derived
from a community connection project in England [43]. All costs are reported in 2019 British
pounds (£) with costs discounted at an annual rate of 3.5% and outcomes at 1.5%, a lower
discount rate which can be used when assessing public health interventions [44].
It is important to always undertake sensitivity analysis as part of any economic mod-
elling. This is due to the fact that there is usually uncertainty on the representativeness of
many parameters in models, for instance, on the level of effectiveness of the intervention, or
the costs associated with different health problems. A number of sensitivity analyses were
conducted to assess the robustness of the analysis. This includes both the univariate sensi-
tivity analysis of specific model parameters, where the model is run varying the values of
key parameters one at a time, as well as probabilistic sensitivity analysis (PSA) using Monte
Carlo simulation modelling In this Monte Carlo simulation, the uncertainty associated
with the variables in Table 1 can be estimated as a probability distribution. This is done by
randomly sampling a value for each of these parameters from within its probability distri-
bution simultaneously and then calculating the incremental cost-effectiveness. We repeat
this exercise 10,000 times. The range over which the parameters are varied will depend on
the assumptions made on their potential distribution. Input variables were assigned beta,
gamma, and log normal shaped distributions, as appropriate [45]. We can then visually
show the results of this PSA on a cost-effectiveness plane, where all 10,000 combinations of
cost and effect can be plotted (See Figure 4 in results section). All analyses are modelled
using TreeAge Pro software (TreeAge Software, LLC, Williamstown, MA, USA).
3. Results
3.1. Summary Results
Summary results of the modelling analysis are presented in Table 2. In the base case
scenario, the incremental cost per loneliness free year gained is £ 768. The total expected
cost per participant in the intervention group over 5 years is £ 7131 compared to £ 6783 in
the usual care group. Over this time period, 0.45 additional loneliness free years would
be gained.
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Table 2. Summary of cost-effectiveness findings (health and social care perspective).
Loneliness Alleviation
Intervention No Intervention
Intervention £ 669 £ 0
GP Visits £ 1399 £ 1467
Depression £ 62 £ 63
Self-Harm £ 55 £ 65
Coronary Heart Disease £ 72 £ 74
Stroke £ 88 £ 90
Dementia £ 649 £ 672
Other residential care £ 3308 £ 3534
Other hospital contacts £ 799 £ 818
Total Cost (95% CI) £ 7131 (£ 5888, 8727) £ 6783 (£ 5429, 8488)
Loneliness Free Years (95% CI) 1.77 (1.43, 2.19) 1.31 (1.15, 1.48)
ICER £ 768 (£ 1632, 358)
3.2. Univariate Sensitivity Analysis
We examined how the results of our analysis change when we varied different in-
dividual variables in the model, one at a time, by up to 20% from their mean values in
Table 1. The results are shown in Figure 2. This shows a “Tornado” diagram, so-called since
it resembles a tornado with the most sensitive impacts of changing any variable shown at
the top of the diagram and the least sensitive at the bottom. A vertical line shows the mean
expected incremental cost effectiveness ratio (ICER) of £ 768 per loneliness free year gained
in our base case scenario. The red bar segments indicate that the value of each parameter
has increased, while the blue segments show that parameter values have fallen. Values to
the right of the vertical base case scenario line indicate a less favourable cost-effectiveness
with the cost per loneliness free year increasing compared to the base case scenario, while
those to the left indicate an improvement in cost-effectiveness with the cost per loneliness
free year gained reducing.
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A probabilistic sensitivity analysis was also performed, using Monte Carlo simula-
tion with 10,000 replications sampled from the distributions presented in Table 1. The 
cost-effectiveness plane for incremental cost-effectiveness of the loneliness alleviation in-
tervention compared to no action from a health and social care perspective is shown in 
Figure 4. The elliptical circle includes 95% of the simulations in the model. In just 3.5% of 
the simulated pairs of costs and outcomes is the intervention dominant over no action, 
that is with lower costs and better outcomes. In the remaining simulations it is more ef-
fective but more costly. 
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Figure 2 shows that the model is very sensitive to changes in the relative effectiveness
of the intervention in reducing the likelihood of being severely lonely. If effectiveness is
reduced by 10%, the ICER would become less favourable rising from £ 768 to £ 1856, while
a 20% reduction in the effect would increase this to £ 8699. In contrast, a 20% improvement
in effectiveness would lead to more favourable ICERs of £ 335 and just £ 96, respectively.
Int. J. Environ. Res. Public Health 2021, 18, 1426 9 of 16
The magnitude of impacts on ICER for all the other factors is much smaller. Figure 3 also
shows the Tornado diagram, this time excluding the most sensitive effectiveness parameter.
In this diagram, the cost of the intervention can be better seen to also have some impact. In
our base case scenario the cost per participant is £ 752, if these costs could be reduced by
20% to £ 602 then the ICER becomes more favourable falling to £ 473, while a 20% increase
in the intervention cost to £ 902 would mean a modestly less favourable ICER of £ 1062.
As Figure 3 shows, changes in other factors including the relative risk of residential care if
severely lonely, costs of residential care, and increased risk of GP contacts have very little
impact on the ICER. In addition to the sensitivity analyses shown in Figures 2 and 3, we
also assessed the impact of setting the discount rate for outcomes at 3.5%, the same rate as
for the costs. This would mean a marginally less favourable ICER of £ 805.




Figure 2. Tornado diagram of the univariate sensitivity analyses. 
  
Figure 3. Tornado diagram of the univariate sensitivity analyses excluding the effectiveness parameter. 
3.3. Probabilistic Sensitvity Analysis 
A probabilistic sensitivity analysis was also performed, using Monte Carlo simula-
tion with 10,000 replications sampled from the distributions presented in Table 1. The 
cost-effectiveness plane for incremental cost-effectiveness of the loneliness alleviation in-
tervention compared to no action from a health and social care perspective is shown in 
Figure 4. The elliptical circle includes 95% of the simulations in the model. In just 3.5% of 
the simulated pairs of costs and outcomes is the intervention dominant over no action, 
that is with lower costs and better outcomes. In the remaining simulations it is more ef-
fective but more costly. 
Figure 3. Tornado diagram of the univariate sensitivity analyses excluding the effectiveness parameter.
3.3. Probab listic Sensitvity Analysis
A probabilistic ens ivity analysis wa also performed, using Monte Carlo simula-
tion with 10,000 replications sampled from the d stributions pres nted in Table 1. The
cost-effectiveness plane for incr mental cost-effectiveness of the lo liness alleviation in-
t rvention compared t no action from a health and soci l car perspective is shown in
Figure 4. The ellipti al circle includes 95% of the simulatio s in the model. In just 3.5% of
the simulated pairs of co ts and outcomes is the inter ti i t over no action, that
is with lower costs and better outcomes. In the remaini g simulations it is more eff ctive
but more costly.
We also constructed a cost-effectiveness acceptability curve. This indicates the prob-
ability that the intervention will be considered cost effective given different levels of
willingness by policymakers to invest in measures to avoid loneliness up to a maximum of
£ 2256, three times the value of the intervention cost. There is no accepted threshold for the
additional time spent without being lonely, so this maximum willingness to pay value is
for illustrative purposes. Ideally, future studies will map changes in levels of loneliness to
levels of quality of life so that the commonly used metric in health economics of cost per
quality adjusted life year gained can be calculated. As Figure 5 illustrates, for our health
and social care perspective model, the intervention has a higher probability of being cost
effective than no action if the willingness to pay reaches £ 836. At the willingness to pay
levels of £ 1000, £ 1500, and £ 2000, respectively the probability of the intervention being
considered cost effective is 59.8%, 79.7%, and 88.9%.
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3.4. Alternative Scenario
Moreov r, w modelled the interventi n taking acc unt of additional informal care
costs associated with strokes [35] and dem ntia [30]. Furthermore, w included some
very marginal economic benefits from participants of a loneliness alleviation programme
themselves becoming volunteers. Table 3 shows the summary results under this scenario,
with a lower ICER of £ 695. The total expected cost per participant in the intervention
group over 5 years is £ 7878 compared to £ 7564 in the usual care group.
In probabilistic sensitivity analysis under this scenario, the intervention has a higher
probability of being cost effective than no action if the willingness to pay level is at least
£ 766. At the willingness to pay levels of £ 1000, £ 1500, and £ 2000, respectively the
probability of the intervention being considered cost effective is 63.1%, 81.2%, and 90.4%.
(See Supplementary for Figure S1 showing the additional cost-effectiveness plane and
Figure S2 with the cost-effectiveness acceptability curve for this scenario).
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Table 3. Summary of cost-effectiveness findings (broader perspective including informal care costs
for stroke and dementia).
Loneliness Intervention No Intervention
Intervention £ 669 £ 0
GP Visits £ 1399 £ 1467
Depression £ 62 £ 63
Self-Harm £ 55 £ 65
Coronary Heart Disease £ 72 £ 74
Stroke £ 315 £ 321
Dementia £ 1180 £ 1222
Other residential care £ 3308 £ 3534
Other hospital contacts £ 799 £ 818
Additional volunteering £ -10 £ 0
Total Cost (95% CI) £ 7878 (£ 6595, 9481) £ 7564 (£ 6179, 9304)
Loneliness Free Years (95% CI) 1.77 (1.43, 2.19) 1.31 (1.15, 1.48)
ICER £ 695
4. Discussion
There is a considerable policy interest in addressing loneliness as a public health
concern. In England, a cross-governmental national strategy was launched in 2018 to
address the issue [9]. The NICE public health guidelines also recommend participation in
group-social activities to tackle social isolation and loneliness as a way of promoting the
mental wellbeing and independence of older people [12].
Reviews of evaluations of interventions that aim to tackle loneliness and social iso-
lation continue to highlight the need to strengthen what is known about their effective-
ness, [46,47]. Randomized controlled trial evidence on support to facilitate social con-
nection and reduce loneliness remains very limited or set in very different country con-
texts [11,48,49]. Many of the approaches used to address loneliness, at least in a UK context,
are provided and funded by non-governmental organisations, often on shoestring budgets,
meaning that any evaluations undertaken tend to be minimal in scope. A recent consen-
sus statement from a group of leading international researchers working in the field of
gerontology and loneliness also concluded that the current evidence base is dominated by
“low-quality trials, small samples, a lack of theoretical frameworks or understanding of
loneliness, diverse or undefined target groups, mixed measures of loneliness and short
follow-up periods to assess longer term impact” [50]. Limits in the robustness of this
evidence-base on what works may make it more difficult for both health service budget
holders and local government authorities, who are responsible for public health in England,
to determine how to combat loneliness.
In addition to wanting more information on what works, these policy makers will
also be interested in the cost-effectiveness of investment in effective measures, that is
whether the additional costs associated with intervention generate sufficient improvements
in outcomes to justify the investment of what are very modest local public health budgets in
England. Formal economic evaluations with loneliness alleviation as the primary outcome,
however, remain rare. A recent systematic review of economic evaluations concluded that
there is a paucity of economic evidence and that further research is needed to identify cost
effective strategies [13].
However, this does not mean that potentially cost effective interventions are not
available. An earlier review noted that even where loneliness was seen as the primary
outcome in the effectiveness part of an evaluation, the economic analysis usually did
not use a loneliness specific outcome [51]. An example of this is a study examining the
cost-effectiveness of an organised community group singing to promote the mental health
of socially isolated and lonely older women in England. This intervention was shown to
be effective with a moderate 60% chance of being considered cost effective in the English
context, but changes in quality of life rather than in loneliness were measured [52]. This
makes it difficult to determine the specific changes in economic costs that can be attributed
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directly to changes in loneliness rather than other impacts of interventions. Another trial
including a cost-effectiveness analysis in the UK that looked at structured professionally
facilitated regular group activities for a community dwelling of older people did find
evidence of significantly reduced loneliness in the intervention group at 24 months, but
the primary focus of the study was on mental wellbeing where no effect was found [53].
Moreover, the authors of that study recognised the limitations of not proactively seeking to
identify and reach older people at risk of poor mental wellbeing.
While a trial evidence on what works is limited, there is evidence on the relationship
between loneliness and health care utilisation that might suggest a potential to avert some
costs through loneliness alleviation. This is mainly drawn from longitudinal observational
studies and can be used to inform models. For instance, a longitudinal analysis of panel
data from the US Health and Retirement Study found an association between increased
contacts with community-based doctors and chronic enduring loneliness, but no impact on
hospital visits was seen [54]. A recent systematic review also suggests weak evidence that
better social relationships may be associated with reduced hospital admissions and length
of stay, but insufficient evidence on the association with use of primary care, outpatient
and community services [55]. An analysis of data from the English Longitudinal Survey of
Ageing suggests that, even when controlling for characteristics such as dementia diagnosis,
loneliness independently is associated with a significantly increased risk of admission
to long-term residential care [23]. This evidence continues to grow, for instance, another
recent study making use of cross-sectional data from the UK’s Biobank reports a significant
association between loneliness and both acute and chronic pain [56].
Given the limited evidence base, we constructed a Markov-decision analysis model
to look at potential levels of cost-effectiveness that might be achieved, assuming that an
effective intervention for loneliness alleviation is available and drawing on longitudinal
studies suggesting that unaddressed loneliness may be associated with poorer levels of
health, as well as more health and social care service utilisation. Our model suggests that if
effective interventions can reduce and help sustain reduced levels of severe loneliness the
value of any health and social care costs averted is unlikely to offset the cost of intervention.
Our probabilistic sensitivity analysis revealed that just 3.5% of iterations of cost and effects
would be cost saving from a health and social care perspective.
Nonetheless, an investment of £ 768 per loneliness free year gained may be a value
that policy makers are willing to pay. Our illustrative real-world loneliness alleviation
programme had a cost per client of £ 752. From a societal perspective, the cost-effectiveness
ratio will be more favourable. We did not fully explore this in our analysis, although we
did observe a reduction in the ICER to £ 695 when including the potential informal care
costs associated with an increased risk of stroke and dementia in the severely lonely, as
well as the positive value of volunteering by intervention clients who themselves become
intervention volunteers.
The ICER will fall further when additional informal care costs for other conditions,
as well as wider impacts such as lost opportunities to engage in volunteering and paid
work beyond the retirement age, are considered. If there is scope to increase the relative
proportion of service users who meet the criteria for severe rather than moderate levels of
loneliness, the case for intervention may be strengthened further. Initiatives to increase
the efficiency of programmes and therefore, reduce costs of delivery, will also improve
cost-effectiveness. We also have conservatively not included any potential health benefits
associated with a reduction in the moderate levels of loneliness, any such benefits would
also improve the ICER.
Although we believe that our modelling analysis serves to illustrate the potential
value of loneliness alleviation measures, there are key limitations that need to be addressed
in further empirical studies. We have, for illustrative purposes, taken as our base scenario
the observed aggregate reduction in loneliness levels routinely collected as part of the
delivery of a loneliness alleviation programme in one area of southern England. There
is no counterfactual group with which to compare incremental changes in loneliness,
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nor can we account for factors such as the availability of alternative community support
services. Ideally, we would have liked to have drawn on effect size from a randomized
controlled trial. Alternatively, in the future, it might be possible to create a counterfactual
individual level simulated population estimate drawing on data from current longitudinal
studies that look at ageing, as well as collecting data on loneliness and levels of community
participation. That said, our estimates of effect may be conservative, a similar uncontrolled
intervention in Wales reported aggregate reductions in loneliness which are double those
used in this model [57].
We have also assumed that if an individual is severely lonely at the end of any
Markov cycle this implies that they have been severely lonely for the entire year, but
their loneliness levels may have varied considerably over this time period. We have also
arbitrarily assumed that a year spent being moderately lonely has half the value of a year
without loneliness. Another gap is a lack of knowledge on recovery from loneliness without
intervention. One novel way in the future of exploring this issue might be for participants
and a counterfactual group to use a mobile app to briefly indicate their current levels of
loneliness on a regular basis. This could help explore the temporal nature of loneliness
and how it ebbs and flows over time. This should be feasible as populations who are more
familiar with these technologies get older. However, our purpose here is to illustrate the
potential impacts of different levels of effect on loneliness rather than make the case for
any individual programme and we have varied estimates of effect in both the univariate
and probabilistic sensitivity analysis to account for uncertainty in our assumptions.
Another limitation is that we do not know enough on the causality of the relationship
between loneliness and any impacts on health status and utilisation. It may be that the onset
of poor health in part exacerbates pre-existing levels of loneliness in our study population.
There may also be some overlapping of potential costs for closely related conditions such
as coronary heart disease and strokes.
In terms of sustained effects consistent with the structure of the Reconnections pro-
gramme that we have taken as our illustrative example, the model assumes that longer term
nominal costs beyond the first year that may be charged for participating in group activities
are borne by the participants themselves or the activity deliverer (such as a charity or
community group). We have considered the impact of variation in sustained participation
in the sensitivity analysis, but even nominal costs of £ 1 or £ 2 per week to a client may be a
deterrent to long term participation in any programme in the real world.
Finally, in addition to recommending further research on both the effectiveness and
cost-effectiveness of loneliness alleviation interventions, we also believe it is important
to undertake work to map across levels of loneliness with validated instruments such
as the UCLA [20] and De Jong Gierveld [58] loneliness scales to quality of life measures
which are commonly in health economics, such as EuroQOL EQ-5D [59] or SF-6D [60].
One recent promising development is an analysis using both the De Jong Gierveld scale
and the 12-Item Short Form Health Survey used in generating SF-6D scores. This study
reported a significant inverse association between increasing loneliness in older people in
five European countries and their physical and mental quality of life [61]. Further work
could be undertaken to assess how these associations impact on utility weights used to
calculate quality adjusted life years. Alternatively, as a standard, economic evaluations of
these interventions could simply assess the impacts on quality of life in addition to impacts
on loneliness. This would allow the cost per quality adjusted life to be calculated and thus
allow an investment in measures to tackle loneliness to be compared with other public
health and health care interventions.
5. Conclusions
Measures that reduce the levels of severe loneliness in older people may potentially be
cost-effective depending on the value that society places on loneliness reduction. However,
they are unlikely to be cost-saving even when making generous assumptions on the long-
term sustained effects and potential adverse health and social care events averted. These
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promising findings justify an investment in well-designed empirical studies to determine
the cost-effectiveness, as well as the willingness to participate in and remain engaged with
measures, such as signposting and other social connection mechanisms, as a means of
reducing loneliness in different contexts and settings.
Supplementary Materials: The following are available online at https://www.mdpi.com/1660-4
601/18/4/1426/s1. Figure S1: Probabilistic sensitivity analysis, loneliness alleviation versus no
action (partial societal perspective); Figure S2: Cost-effectiveness acceptability curve (partial societal
perspective).
Author Contributions: Conceptualization, D.M.; methodology, D.M. and AL.P.; formal analysis,
D.M. and AL.P.; writing—original draft preparation, D.M.; writing—review and editing, D.M. and
AL.P. Both authors have read and agreed to the published version of the manuscript. Both authors
have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Acknowledgments: We would like to thank Tara Rowe, Janet (Jet) Powell, and Ben Jupp at the Social
Finance and Sophie Pryce at Age UK Hereford and Worcester for information on the Reconnections
service delivered in Worcestershire.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Perlman, D.; Peplau, L. Theoretical approaches to loneliness. In Loneliness: A Sourcebook of Current Theory, Research and Therapy;
Peplau, L., Perlman, D., Eds.; John Wiley & Sons: New York, NY, USA, 1982; pp. 123–134.
2. Nyqvist, F.; Victor, C.R.; Forsman, A.K.; Cattan, M. The association between social capital and loneliness in different age groups:
A population-based study in Western Finland. BMC Public Health 2016, 16, 542. [CrossRef]
3. Courtin, E.; Knapp, M. Social isolation, loneliness and health in old age: A scoping review. Health Soc. Care Community 2017, 25,
799–812. [CrossRef]
4. Lee, S.L.; Pearce, E.; Ajnakina, O.; Johnson, S.; Lewis, G.; Mann, F.; Pitman, A.; Solmi, F.; Sommerlad, A.; Steptoe, A.; et al. The
association between loneliness and depressive symptoms among adults aged 50 years and older: A 12-year population-based
cohort study. Lancet Psychiatry 2020, 8, 48–57. [CrossRef]
5. Valtorta, N.K.; Kanaan, M.; Gilbody, S.; Ronzi, S.; Hanratty, B. Loneliness and social isolation as risk factors for coronary heart
disease and stroke: Systematic review and meta-analysis of longitudinal observational studies. Heart 2016, 102, 1009–1016.
[CrossRef]
6. Holwerda, T.J.; van Tilburg, T.G.; Deeg, D.J.; Schutter, N.; Van, R.; Dekker, J.; Stek, M.L.; Beekman, A.T.; Schoevers, R.A. Impact of
loneliness and depression on mortality: Results from the Longitudinal Ageing Study Amsterdam. Br. J. Psychiatry 2016, 209,
127–134. [CrossRef]
7. Tabue Teguo, M.; Simo-Tabue, N.; Stoykova, R.; Meillon, C.; Cogne, M.; Amieva, H.; Dartigues, J.F. Feelings of Loneliness and
Living Alone as Predictors of Mortality in the Elderly: The PAQUID Study. Psychosom. Med. 2016, 78, 904–909. [CrossRef]
[PubMed]
8. Holt-Lunstad, J.; Smith, T.B.; Baker, M.; Harris, T.; Stephenson, D. Loneliness and social isolation as risk factors for mortality: A
meta-analytic review. Perspect. Psychol. Sci. 2015, 10, 227–237. [CrossRef] [PubMed]
9. HM Government. A Connected Society. A Strategy for Tackling Loneliness—Laying the Foundations for Change; Department for Digital,
Culture, Media and Sport: London, UK, 2018.
10. Hogan, E. Covid Lockdowns Turn Loneliness into a Killer. Available online: https://www.thetimes.co.uk/article/covid-
lockdowns-turn-loneliness-into-a-killer-s5l96m68h (accessed on 14 October 2020).
11. Poscia, A.; Stojanovic, J.; La Milia, D.I.; Duplaga, M.; Grysztar, M.; Moscato, U.; Onder, G.; Collamati, A.; Ricciardi, W.; Magnavita,
N. Interventions targeting loneliness and social isolation among the older people: An update systematic review. Exp. Gerontol.
2018, 102, 133–144. [CrossRef] [PubMed]
12. National Institute for Health and Care Excellence. Older People: Independence and Mental Wellbeing. NICE Guideline NG32; National
Institute for Health and Care Excellence: London, UK, 2015.
13. Mihalopoulos, C.; Le, L.K.; Chatterton, M.L.; Bucholc, J.; Holt-Lunstad, J.; Lim, M.H.; Engel, L. The economic costs of loneliness:
A review of cost-of-illness and economic evaluation studies. Soc. Psychiatry Psychiatr. Epidemiol. 2020, 55, 823–836. [CrossRef]
[PubMed]
14. Briggs, A.; Sculpher, M.; Claxton, K. Decision Modelling for Health Economic Evaluation; Oxford University Press: Oxford, UK, 2006.
15. DelaCruz, J.J.; Brennan-Ing, M.; Kakolyris, A.; Martinez, O. The Cost Effectiveness of Mental Health Treatment in the Lifetime of
Older Adults with HIV in New York City: A Markov Approach. Pharm. Open 2020, 1–16. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2021, 18, 1426 15 of 16
16. de Jong, L.A.; van der Velden, A.W.G.; Hulst, M.V.; Postma, M.J. Cost-effectiveness analysis and budget impact of rivaroxaban
compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism. BMJ Open 2020, 10, e039057.
[CrossRef]
17. Al Khayat, M.; Eijsink, J.F.H.; Postma, M.J.; Wilschut, J.C.; van Hulst, M. The Cost-Effectiveness of Hepatitis C Virus Screening
Strategies among Recently Arrived Migrants in the Netherlands. Int. J. Environ. Res. Public Health 2020, 17, 6091. [CrossRef]
18. McDaid, D.; Park, A.-L.; Knapp, M. Commissioning Cost-Effective Services for Promotion of Mental Health and Wellbeing and Prevention
of Mental Ill-Health; Public Health England: London, UK, 2017.
19. Social Finance. Reconnections. Available online: https://www.socialfinance.org.uk/projects/reconnections (accessed on 24
December 2020).
20. Russell, D.; Peplau, L.A.; Cutrona, C.E. The revised UCLA Loneliness Scale: Concurrent and discriminant validity evidence. J.
Personal. Soc. Psychol. 1980, 39, 472. [CrossRef]
21. Boshuizen, H.C.; van Baal, P.H. Probabilistic sensitivity analysis: Be a Bayesian. Value Health 2009, 12, 1210–1214. [CrossRef]
[PubMed]
22. Reconnections. Estimate provided by Reconnections team. 2019.
23. Kuiper, J.S.; Zuidersma, M.; Voshaar, R.C.O.; Zuidema, S.U.; van den Heuvel, E.R.; Stolk, R.P.; Smidt, N. Social relationships
and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies. Ageing Res. Rev. 2015, 22, 39–57.
[CrossRef]
24. Stickley, A.; Koyanagi, A. Loneliness, common mental disorders and suicidal behavior: Findings from a general population
survey. J. Affect. Disord. 2016, 197, 81–87. [CrossRef] [PubMed]
25. Hanratty, B.; Stow, D.; Moore, D.C.; Valtorta, N.K.; Matthews, F. Loneliness as a risk factor for care home admission in the English
Longitudinal Study of Ageing. Age Ageing 2018, 47, 896–900. [CrossRef]
26. Ellaway, A.; Wood, S.; Macintyre, S. Someone to talk to? The role of loneliness as a factor in the frequency of GP consultations. Br.
J. Gen. Pract. 1999, 49, 363–367.
27. Dreyer, K.; Steventon, A.; Fisher, R.; Deeny, S.R. The association between living alone and health care utilisation in older adults: A
retrospective cohort study of electronic health records from a London general practice. BMC Geriatr. 2018, 18, 269. [CrossRef]
[PubMed]
28. Cantarero-Prieto, D.; Pascual-Sáez, M.; Blázquez-Fernández, C. Does social isolation affect medical doctor visits? New evidence
among European older adults. Appl. Res. Qual. Life 2019, 1–18. [CrossRef]
29. NHS England. 2019/20 National Tariff Payment System: National Prices and Prices for Emergency Care Services; NHS England: London,
UK, 2019.
30. NHS England; NHS Improvement. National Cost Collection 2019: For Data Relating to 2018/19: Commentary on Headlines and
Introduction to the Available Data; NHS England and NHS Improvement: London, UK, 2020.
31. Walker, S.; Asaria, M.; Manca, A.; Palmer, S.; Gale, C.P.; Shah, A.D.; Abrams, K.R.; Crowther, M.; Timmis, A.; Hemingway, H.;
et al. Long-term healthcare use and costs in patients with stable coronary artery disease: A population-based cohort using linked
health records (CALIBER). Eur. Heart J. Qual. Care Clin. Outcomes 2016, 2, 125–140. [CrossRef]
32. Wittenberg, R.; Knapp, M.; Hu, B.; Comas-Herrera, A.; King, D.; Rehill, A.; Shi, C.; Banerjee, S.; Patel, A.; Jagger, C.; et al. The
costs of dementia in England. Int. J. Geriatr. Psychiatry 2019, 34, 1095–1103. [CrossRef] [PubMed]
33. Radhakrishnan, M.; Hammond, G.; Jones, P.B.; Watson, A.; McMillan-Shields, F.; Lafortune, L. Cost of improving Access to
Psychological Therapies (IAPT) programme: An analysis of cost of session, treatment and recovery in selected Primary Care
Trusts in the East of England region. Behav. Res. 2013, 51, 37–45. [CrossRef]
34. Curtis, L.; Burns, A. Unit Costs of Health and Social Care 2019; PRRSU, University of Kent: Canterbury, UK, 2019.
35. Tsiachristas, A.; McDaid, D.; Casey, D.; Brand, F.; Leal, J.; Park, A.L.; Geulayov, G.; Hawton, K. General hospital costs in England
of medical and psychiatric care for patients who self-harm: A retrospective analysis. Lancet Psychiatry 2017, 4, 759–767. [CrossRef]
36. Patel, A.; Berdunov, V.; Quayyum, Z.; King, D.; Knapp, M.; Wittenberg, R. Estimated societal costs of stroke in the UK based on a
discrete event simulation. Age Ageing 2020, 49, 270–276. [CrossRef] [PubMed]
37. Institute for Health Metrics and Evaluation. Global Burden of Disease 2019 Incidence Data for England. Available online:
http://ghdx.healthdata.org/gbd-results-tool (accessed on 24 December 2020).
38. Public Health England. Public Health Profiles: Depression QOF Incidence—New Diagnosis for England 2018/19. Available
online: https://fingertips.phe.org.uk/ (accessed on 24 December 2020).
39. Clements, C.; Turnbull, P.; Hawton, K.; Geulayov, G.; Waters, K.; Ness, J.; Townsend, E.; Khundakar, K.; Kapur, N. Rates of
self-harm presenting to general hospitals: A comparison of data from the Multicentre Study of Self-Harm in England and Hospital
Episode Statistics. BMJ Open 2016, 6, e009749. [CrossRef]
40. Wittenberg, R. Information on Care Home Prevalence and Incidence Estimates Drawn from CPEC Model of Demands and Costs of Social
Care; CPEC: London, UK, 2020.
41. Office for National Statistics. National Life Tables: England (Three Year Average 2017–2019); ONS: London, UK, 2020.
42. Hobbs, F.D.R.; Bankhead, C.; Mukhtar, T.; Stevens, S.; Perera-Salazar, R.; Holt, T.; Salisbury, C. Clinical workload in UK primary
care: A retrospective analysis of 100 million consultations in England, 2007–2014. Lancet 2016, 387, 2323–2330. [CrossRef]
43. GOV.UK. National Minimum Wage and National Living Wage Rates. Available online: https://www.gov.uk/national-minimum-
wage-rates (accessed on 24 December 2020).
Int. J. Environ. Res. Public Health 2021, 18, 1426 16 of 16
44. Darch, K. Gloucestershire Village and Community Agents. Cost-Benefit Analysis; Gloucestershire County Council: Gloucester, UK,
2014.
45. National Institute for Health and Care Excellence. Developing NICE Guidelines: The Manual; NICE: London, UK, 2014.
46. Veazie, S.; Gilbert, J.; Winchell, K.; Paynter, R.; Guise, J.-M. Addressing Social Isolation to Improve the Health of Older Adults: A Rapid
Review; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2019.
47. Jopling, K. Promising Approaches Revisited: Effective Action on Loneliness in Later Life; Campaign to End Loneliness: London, UK,
2020.
48. Cohen-Mansfield, J.; Perach, R. Interventions for alleviating loneliness among older persons: A critical review. Am. J. Health
Promot. 2015, 29, e109–e125. [CrossRef]
49. Coll-Planas, L.; Nyqvist, F.; Puig, T.; Urrútia, G.; Solà, I.; Monteserín, R. Social capital interventions targeting older people and
their impact on health: A systematic review. J. Epidemiol. Community Health 2017, 71, 663–672. [CrossRef]
50. Prohaska, T.; Burholt, V.; Burns, A.; Golden, J.; Hawkley, L.; Lawlor, B.; Leavey, G.; Lubben, J.; O’Sullivan, R.; Perissinotto, C.;
et al. Consensus statement: Loneliness in older adults, the 21st century social determinant of health? BMJ Open 2020, 10, e034967.
[CrossRef] [PubMed]
51. McDaid, D.; Bauer, A.; Park, A.-L. Making the Economic Case for Investing in Actions to Prevent and/or Tackle Loneliness: A Systematic
Review; LSE Consulting: London, UK, 2017.
52. Coulton, S.; Clift, S.; Skingley, A.; Rodriguez, J. Effectiveness and cost-effectiveness of community singing on mental health-related
quality of life of older people: Randomised controlled trial. Br. J. Psychiatry J. Ment. Sci. 2015, 207, 250–255. [CrossRef]
53. Mountain, G.; Windle, G.; Hind, D.; Walters, S.; Keertharuth, A.; Chatters, R.; Sprange, K.; Craig, C.; Cook, S.; Lee, E.; et al. A
preventative lifestyle intervention for older adults (lifestyle matters): A randomised controlled trial. Age Ageing 2017, 46, 627–634.
[CrossRef]
54. Gerst-Emerson, K.; Jayawardhana, J. Loneliness as a public health issue: The impact of loneliness on health care utilization among
older adults. Am. J. Public Health 2015, 105, 1013–1019. [CrossRef] [PubMed]
55. Valtorta, N.K.; Moore, D.C.; Barron, L.; Stow, D.; Hanratty, B. Older adults’ social relationships and health care utilization: A
systematic review. Am. J. Public Health 2018, 108, e1–e10. [CrossRef] [PubMed]
56. Allen, S.F.; Gilbody, S.; Atkin, K.; van der Feltz-Cornelis, C. The associations between loneliness, social exclusion and pain in the
general population: A N=502,528 cross-sectional UK Biobank study. J. Psychiatr. Res. 2020, 130, 68–74. [CrossRef]
57. Roberts, J.R.; Windle, G. Evaluation of an intervention targeting loneliness and isolation for older people in North Wales. Perspect.
Public Health 2020, 140, 153–161. [CrossRef]
58. Gierveld, J.D.J.; Tilburg, T.V. A 6-item scale for overall, emotional, and social loneliness: Confirmatory tests on survey data. Res.
Aging 2006, 28, 582–598. [CrossRef]
59. EuroQol Group. EuroQol—A new facility for the measurement of health-related quality of life. Health Policy 1990, 16, 199–208.
[CrossRef]
60. Brazier, J.; Roberts, J.; Deverill, M. The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 2002, 21,
271–292. [CrossRef]
61. Tan, S.S.; Fierloos, I.N.; Zhang, X.; Koppelaar, E.; Alhambra-Borras, T.; Rentoumis, T.; Williams, G.; Rukavina, T.; van Staveren, R.;
Garces-Ferrer, J.; et al. The Association between Loneliness and Health Related Quality of Life (HR-QoL) among Community-
Dwelling Older Citizens. Int. J. Environ. Res. Public Health 2020, 17, 600. [CrossRef] [PubMed]
